You are here

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
City of Hope National Medical Center
Duarte, California, 91010 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Myeloid Leukemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Ph+ CML or Ph+ ALL who are primarily refractory to full-dose imatinib (600 mg), have
disease progression/relapse while on full-dose imatinib, or are intolerant of any dose
of imatinib.

- At least 3 months post stem cell transplantation

- Able to take daily oral capsules/tablets reliably

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with Philadelphia chromosome, and bcr-abl negative CML

- Overt leptomeningeal leukemia

- Subjects without evidence of leukemia in bone marrow (extramedullary disease only)

NCT00261846
Pfizer
Completed
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Chronic Myeloid Leukemia
NCT00574873
All Genders
18+
Years
Multiple Sites
Chronic Myeloid Leukemia
NCT00261846
All Genders
18+
Years
Multiple Sites
Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)
NCT01374139
All Genders
21+
Years
Singapore,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now